Skip to content

The Effects of Cognitive Dual-Tasking in Later Stages of Rehabilitation After ACL Reconstruction

The Effects of Cognitive Dual-Tasking in Later Stages of Rehabilitation After ACL Reconstruction

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06206200
Acronym
AMIRA
Enrollment
80
Registered
2024-01-16
Start date
2023-10-15
Completion date
2027-04-01
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL Injury, Anterior Cruciate Ligament Reconstruction, Athrogenic Muscle Responses

Brief summary

Anterior cruciate ligament (ACL) injuries are common in sports and often require a long and challenging rehabilitation process. Athletes who sustain these injuries typically engage in pivoting and cutting sports, where these motor tasks must be performed simultaneously with cognitive tasks such as decision-making and keeping an eye on the opponent. Directing attention to both cognitive and motor tasks leads to cognitive-motor interference, which is associated with movement patterns that increase the risk of ACL (re)injury. Therefore, it is crucial that before returning to such demanding sports after ACL reconstruction, athletes sufficiently develop and automate safe yet efficient motor skills to free up attentional capacity for decision-making, thereby reducing the risk of suboptimal movement patterns and reinjury. However, current rehabilitation programs often primarily focus on the motor component in a single-task manner, giving insufficient attention to the cognitive component that is inseparable from sports. This randomized controlled trial aims to investigate the effects of implementing motor-cognitive dual tasks in the end phase rehabilitation after ACL reconstruction on muscle function, functional outcomes, and patient-reported outcomes.

Interventions

OTHERCognitive dual task training (intervention group)

Simultaneously performing cognitive tasks and motor rehabilitative exercises.

OTHERStandard of care physiotherapy (control group)

The current best physical therapy treatment for patients with anterior cruciate ligament reconstruction based on existing scientific evidence.

Sponsors

Research Foundation Flanders
CollaboratorOTHER
University Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* 18-40 years old. * Having suffered an ACL rupture. * Undergoing a surgical ACL reconstruction in the AZ Delta hospital in Roeselare (Campus Brugsesteenweg).

Exclusion criteria

* Revision ACL reconstruction. * Other severe injuries to the lower limbs within the past year. * Muscle or neurological disorders affecting lower limb functioning. * Fibromyalgia or chronic fatigue syndrome.

Design outcomes

Primary

MeasureTime frameDescription
Jumping height in hop tests5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)Performance in single hop tests and a single leg drop-jump expressed by jump height in centimeters.
Patient reported knee function5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)Questioned using the Knee Injury and Osteoarthritis Outcome Score (KOOS) with its different subscores. Scores on the KOOS range from 0-100, with 0 representing the greatest possible problems in terms of knee function and 100 representing no problems.
Psychological readiness to return to sport5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)Questioned using the ACL-RSI. Scores range from 0 to 100. Higher scores indicate higher psychological readiness.
Quadriceps and hamstrings activity / cocontraction during hop tasks5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)Electromyographical measurement of quadriceps and hamstrings activation during hop tasks.
Voluntary quadriceps activation5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)A force-based isometric biodex measurement using the interpolated twitch/superimposed burst technique.
Activity level5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)Questioned using the Tegner Score. The scores range from 0 to 10, with higher scores indicating higher activity levels.

Secondary

MeasureTime frameDescription
The amount of pain that the subjects experience.5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)Questioned using a Numeric Rating Scale. The scores range between 0 and 10 with 10 0representing the highest level of pain.
Quadriceps and hamstrings strength5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)Measured on the biodex.
Kinesiophobia5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)Questioned using the Tampa Scale of Kinesiophobia (TSK). Scores on the TSK range from 17 to 68, with higher scores indicating more kinesiophobia.
Subjective knee stability5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)Questioned using the first question of the Lysholm questionnaire. Scores range from 0 to 25 with 25 indicating no symptoms of subjective instability.

Other

MeasureTime frameDescription
Duration of ground contact in hop tests5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)Performance in single hop tests and a single leg drop-jump expressed by the duration of ground contact.
Expectations regarding return to sport5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)Questioned using the Tegner Score: 'how active do you want to be at the end of your rehabilitation?'. The scores range from 0 to 10, with higher scores indicating higher activity levels.
Strength endurance during timed single leg step down and timed single leg squat5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)The strength endurance of the subjects will be evaluated by the amount of repetitions they can perform in a time span of 30 seconds.
Performance in the T-agility test5 months post ACL reconstruction (= prior to intervention); 7 months post ACL reconstruction (= after the intervention); 9 months post ACL reconstruction (= after a 2 month retention period)It will be measured how much time subjects require to complete a T-agility test.

Countries

Belgium

Contacts

Primary ContactEvy Deschaumes, MSc
evy.deschaumes@ugent.be+32 9 332 5503
Backup ContactErik Witvrouw, prof. dr.
erik.witvrouw@ugent.be+32 9 332 26 32

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026